Pfizer tops Street 1Q forecasts on higher sales, lower taxes
Pfizer easily beat Wall Street expectations as the biggest U.S. drugmaker's first-quarter net income jumped 27 percent due to higher sales, a lower tax bill and some one-time gains. The company raised its 2016 financial forecasts, citing the strong quarter…